ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 210 filers reported holding ARGENX SE in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,601,854 | +912.8% | 115,131 | +667.5% | 0.38% | +683.7% |
| Q1 2023 | $5,588,700 | -71.0% | 15,000 | -72.5% | 0.05% | -78.1% |
| Q3 2022 | $19,241,000 | -27.8% | 54,500 | -22.5% | 0.22% | -26.6% |
| Q2 2022 | $26,647,000 | -1.4% | 70,331 | -17.9% | 0.30% | +2.3% |
| Q1 2022 | $27,021,000 | +91.1% | 85,696 | +112.3% | 0.30% | +82.8% |
| Q4 2021 | $14,138,000 | +643.7% | 40,371 | +34.1% | 0.16% | +986.7% |
| Q4 2017 | $1,901,000 | -30.7% | 30,100 | -75.2% | 0.02% | -25.0% |
| Q3 2017 | $2,743,000 | +8.5% | 121,313 | +1.8% | 0.02% | -4.8% |
| Q2 2017 | $2,527,000 | – | 119,146 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |